Export 4 results:
Author Title [ Type(Desc)] Year
Filters: Author is Beck, Allison  [Clear All Filters]
Journal Article
N. Rouphael, Beck, A., Kirby, A. E., Liu, P., Natrajan, M. S., Lai, L., Phadke, V., Winston, J., Raabe, V., Collins, M. H., Girmay, T., Alvarez, A., Beydoun, N., Karmali, V., Altieri-Rivera, J., Lindesmith, L. C., Anderson, E. J., Wang, Y., El-Khorazaty, J., Petrie, C., Baric, R. S., Baqar, S., Moe, C. L., and Mulligan, M. J., Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum., J Infect Dis, 2022.
L. Lai, Ault, K., Rouphael, N., Beck, A., Domjahn, B., Xu, Y., Anderson, E. J., Cheng, A., Nakamura, A., Hoagland, R. J., Kelley, C., Edupuganti, S., Mask, K., Nesin, M., Unger, E. R., Panicker, G., David, H., and Mulligan, M. J., Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure., Vaccines (Basel), vol. 8, no. 3, 2020.
N. G. Rouphael, Hurwitz, S. J., Hart, M., Beck, A., Anderson, E. J., Deye, G., Osborn, B., Cai, S. Yi, Focht, C., Amegashie, C., Bowlin, T. L., Brooks, J., and Mulligan, M. J., Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers., Antimicrob Agents Chemother, vol. 63, no. 9, 2019.
M. J. Mulligan, Stapleton, J. T., Keitel, W. A., Frey, S. E., Chen, W. H., Rouphael, N., Edupuganti, S., Beck, A., Winokur, P. L., Sahly, H. M. El, Patel, S. M., Atmar, R. L., Graham, I., Anderson, E., El-Kamary, S. S., Pasetti, M. F., Sztein, M. B., Hill, H., and Goll, J. B., Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial., Vaccine, vol. 35, no. 36, pp. 4730-4737, 2017.